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Introduction
IgG are a major fraction of immunoglobulins produced by plasma cells in lymphoid organs that comprise ~20% of serum proteins. IgG bind to antigens to induce an inflammatory response or form immune complexes [1] . It is widely known that patients with connective tissue diseases, especially those with Sjögren's syndrome (SS), systemic lupus erythematosus (SLE), or mixed connective tissue disease (MCTD), display hypergammaglobulinemia or a high IgG titer. IgG is used to evaluate the effects of immunosuppressive therapy, and some autoantibody titers are known to be related to disease activity, for example, anti-double strand DNA antibody titers are related to lupus nephritis and its activity [2] [3] [4] , and a previous report demonstrated that the IgG level is associated with lymphoid infiltration in SS [5] . However, the effects of seasonal changes in the IgG levels of patients with connective tissue diseases have never been considered. During our daily medical practice, we have noticed that connective tissue diseases patients show seasonal changes in their IgG levels regardless of their medication; therefore, we conducted a retrospective chart review of a large number of connective tissue diseases patients at our hospital to verify our hypothesis.
Materials and Methods

Cases and controls
450 Patients with connective tissue diseases who were followed-up at Kyoto University Hospital for whom both summer (July and August) and winter (January and Basic information of each group was shown in Table 1 . Connective tissue diseases patients fulfilled the criteria of each disease, namely, ACR criteria for RA [6] , SLE [7] , SSc [8] , Japanese criteria for primary SS [9] , criteria for MCTD [10] and criteria for PM 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 and DM [11] . Table 2 ). This tendency was kept in other 3 years (Table 2 ). To confirm these results, we evaluated another independent set containing 355 connective tissue disease patients who were followed-up around the same time as the first set. The second set also showed that the connective tissue disease patients had higher IgG levels in summer than in winter in all the four years ( IgG seasonal change found in connective tissue disease was observed in general. As a result, we could not find any regular tendency of ratio value of positive ΔIgG in this group (Table 2) . Logistic regression analysis using these patients and connective tissue disease patients demonstrated that the positive ΔIgG was associated with to have connective tissue diseases even after adjustment by serum IgG levels at baseline, age, sex, and treatment (Table 3) .
Next we analyzed the data with stringent cut off (ΔIgG >10mg/dl as positive change and -10mg/dl >ΔIgG as negative change) to exclude the possibility that just subtle seasonal movement of serum IgG level greatly influenced on the overall ratio value of positive ΔIgG. There is a possibility that change of temperature, humidity and so on between the seasons may influence on machinery to cause subtle change. We observed the same tendency of IgG movement even with stringent cutoff in connective tissue diseases and each connective tissue disease subgroup (Supplementary Table 1 ).
The reference group did not show a regular tendency. When we set more stringent cut off (ΔIgG >100mg/dl as positive change and -100mg/dl >ΔIgG as negative change), we observed the same results in all groups (Supplementary Table 2 ). From these, we concluded that the seasonal variations of serum IgG we found in the current study were not due to some kinds of errors in machinery or sampling bias.
As the SLE subgroup shows clear seasonal variations of serum IgG among connective tissue diseases and it is a large part of patients with connective tissue diseases in this study, we chose the SLE patients to assess the correlation of ΔIgG with disease activity. The successive data of anti-DNA antibody, C3, C4, CH50, and urine protein were obtained for the SLE patients. We compared the changes of these markers for SLE activity with ΔIgG in the patients. While we could not observe meaningful association between ΔIgG and seasonal change of C3, C4, CH50 or urine protein, we found that ΔIgG was moderately correlated with the seasonal change of anti-DNA antibody in 2009 (rho(Spearman's rank-sum coefficient)=0.35, p=1.6x10 -5 ). We found that this correlation was kept in other three years (rho is 0.30 or larger). Even when we chose SLE patients demonstrating a stringent changes of anti-DNA antibody (Δanti-DNA >=5 IU/ml or -5 IU/ml>=Δanti-DNA), we observed rather strong correlation between the two markers in 2009 (rho=0.47, p=0.013, Figure 1a ). We found that this tendency was also seen in other three years (rho is 0.52 or larger).
Next we obtained DAS28 score of 40 RA patients in 2009, the standard measurement to evaluate clinical activity of RA, and analyzed whether ΔIgG correlated with the change of DAS28 or not. We detected moderate correlation between them (rho=0.39, p=0.012, Figure 1b ). This correlation was observed in other three years (rho 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 is 0.28 or larger).
Discussion
It is widely known that many autoimmune diseases are associated with hypergammaglobulinemia mainly consisting of IgG. In some diseases, hypergammaglobulinemia has been suggested to be associated with disease activity, such as lymphoid cell infiltration, treatment responsiveness, and pulmonary arterial hypertension in SS [5, 12] . Another previous report stated that hypergammaglobulinemia in children presenting with SLE-like symptoms is a predictive factor for developing MCTD [13] . However, no previous reports have evaluated the seasonal change in IgG on a large scale. Here, we showed that more than half of patients with connective tissue diseases demonstrated higher IgG levels in summer than in winter and that some of the seasonal variations may correlate with disease activity to some extent.
When we focus on patients with connective tissue diseases whose IgG data were frequently measured to determine two seasons to compare in the preliminary study, the movement of their IgG titers throughout the year suggested that IgG levels in spring and autumn are between the levels in summer and winter (data not shown). This indicates that our comparison between the two seasons in the current study is enough to assess seasonal variation of serum IgG. Moreover, to compare specific two seasons seems good to avoid multiple testing which increases type 1 error of the statistics.
In this study, we analyzed two independent set of samples with connective tissue diseases and found that this tendency of seasonal variation of IgG levels was kept for all the four years. We observed this tendency in each connective tissue disease and in patients with SLE in particular. As we could not obtain IgG data for healthy people, we used data from 488 patients without connective tissue diseases as reference. They have variable diseases from variable departments, such as eczema, IgA nephropathy, HTLV-1 infection, and malignant lymphoma. As a result, they did not show a regular tendency. Although it's much better to use data from age and sex-matched healthy people as control, the result obtained from reference group suggests that the seasonal change of serum IgG levels is not seen in general. Moreover, the logistic regression analysis did not significantly alter the association between seasonal variation of IgG and connective tissue diseases, even with adjustment by age, sex, treatment, and serum IgG level at baseline. When these variations were mainly comprised by very small variations of IgG such as less than 10 mg/dl, some might argue that they are not fully convincing.
These small changes may include some machinery errors. However, when we set Seasonal effects on the onset, relapse, and disease activity of some connective tissue diseases have been reported. In general, SLE activity is believed to increase in spring and summer due to sunlight exposure [14] . However, there are also conflicting reports showing no seasonal change in lupus activity [15] [16] . The influence of season on PM/DM is also disputed [17] [18] . Therefore, it does not seem that the seasonal IgG changes seen in connective tissue diseases patients are solely due to disease activity. It is possible that the use of additional medications including immunosuppressants or corticosteroids to suppress disease flare-up in winter affected our results. However, logistic regression analysis did not alter the association after adjustment of treatment.
Moreover, patients with primary SS, in whom immunosuppressants or corticosteroids are scarcely used, also showed the same tendency, suggesting that this possibility cannot fully explain the phenomena.
The IgG change in the connective tissue diseases patients seemed to be proportional to the temperature throughout the year, but it is unlikely that the change in IgG is caused by temperature changes because the reference group did not show a similar tendency. When we compared the IgG level with the mean temperature in Kyoto, the correlation between them was highly variable from patient to patient (data not shown).
The difference between the patients with connective tissue diseases and those without them might reflect a difference in B cell function between the two groups. To elucidate whether other immunoglobulin fractions act in the same manner as IgG, we analyzed IgA and IgM in a similar manner. However, we could not find any regular tendency of seasonal change in IgA or IgM in either the controls or connective tissue 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 disease patients (data not shown).
We do not know the underlying mechanisms of this IgG change in connective tissue disease patients. Further analysis should be performed to address this question. To investigate whether this change is related to temperature, it would be interesting and feasible to investigate the ΔIgG in patients with connective tissue diseases in the Southern Hemisphere .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Acknowledgements: none Statement: none   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
Conflicts of interest
Figure legend 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 65 tissue diseases in the first set, second set, and combined sets were indicated, those in patients with each connective tissue disease in the combined sets were shown. Positive ratio indicates a ratio value of patients whose IgG levels were higher in summer than in winter in each year. When a patient had more than two connective tissue diseases, overlapping in more than two groups was allowed.
P-values were calculated using the binomial test. 20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Figure Click here to download high resolution image
